Publications

<< back

• Prof. Sylvie Bastuji-Garin
  
  Selected publications of Prof. Sylvie Bastuji-Garin in the field of dermato-epidemiology
  
  Sbidian E/Bastuji-Garin S*, Valeyrie-Allanore L, Ferkal S, Lefaucheur JP, Drouet A, Brugière P, Vialette C, Combemale P, Barbarot S, Wolkenstein P*. At-Risk Phenotype of Neurofibromatose-1 Patients: A Multicentre Case-Control Study. Orphanet J Rare Dis. 2011 Jul 13 (sous presse) *Co-premiers auteurs
  
  Duong TA, Bastuji-Garin S, Valeyrie-Allanore L, Sbidian E, Ferkal S, Wolkenstein P. Evolving pattern with age of cutaneous signs in neurofibromatosis 1: A cross-sectional study of 728 patients. Dermatology 2011 May 4 (sous presse)
  
  Duong TA, Sbidian E, Valeyrie-Allanore L, Vialette C, Ferkal S, Hadj-Rabia S, Glorion C, Lyonnet S, Zerah M, Kemlin I, Rodriguez D, Bastuji-Garin S*/Wolkenstein P*. Mortality Associated with Neurofibromatosis 1: A Cohort Study of 1895 Patients in 1980-2006 in France. Orphanet J Rare Dis. 2011 May 4;6:18 *
  
  Bastuji-Garin S, Joly P, Lemordant P, Sparsa A, Bedane C, Delaporte E, Roujeau JC, Bernard P, Guillaume JC, Ingen-Housz-Oro S, Maillard H, Pauwels C, Picard-Dahan C, Dutronc Y, Richard MA; French Study Group for Bullous Diseases. Risk factors for bullous pemphigoid in the elderly: a prospective case-control. J Invest Dermatol. 2011 Mar;131(3):637-43.
  
  Sbidian E, Wolkenstein P, Valeyrie-Allanore L, Rodriguez D, Hadj-Rabia, Ferkal S, Lacour JP, Leonard JC, Taillandier L, Sportich S, Berbis P, Bastuji-Garin S. NF1Score: A Prediction Score for Internal Neurofibromas in Neurofibromatosis-1. J Invest Dermatol. 2010 ;130 :2173-8
  
  Joly P, Bastuji-Garin S, Frances C, Lebbe C, Aubin F, Penso-Assathiany D, D’Incan M, Avril MF, Lair G, Barette S, Euvrard S. Squamous cell carcinoma are associated with verrucokeratotic cutaneous lesions but not with common warts in organ-transplant patients. A case-control study. Transplantation 2010; 89:1224-30
  
  Hello M, Barbarot S, Bastuji-Garin S, Revuz J, Chosidow O. Use of Thalidomide for Severe Recurrent Aphthous Stomatitis: A Multicenter Cohort Analysis. Medicine (Baltimore) 2010;89:176-82
  
  Wolkenstein P, Rodriguez D, Ferkal S, Gravier H, Buret V, Algans N, SimeoniMC, Bastuji-Garin S. Impact of neurofibromatosis 1 upon quality of life inchildhood: a cross-sectional study of 79 cases. Br J Dermatol. 2009 Apr;160(4):844-8.
  
  Bastuji-Garin S, Sbidian E. How to validate outcome instruments for pemphigus. J Invest Dermatol. 2009 Oct;129(10):2328-30. PubMed PMID: 19749779.
  
  Wolkenstein P, Revuz J, Roujeau JC, Bonnelye G, Grob JJ, Bastuji-Garin S;French Society of Dermatology. Psoriasis in France and associated risk factors:results of a case-control study based on a large community survey. Dermatology. 2009;218(2):103-9. Epub 2008 Dec 6.
  
  Canoui-Poitrine F, Revuz JE, Wolkenstein P, Viallette C, Gabison G, Pouget F, Poli F, Faye O, Bastuji-Garin S. Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity. J Am Acad Dermatol. 2009 Jul;61(1):51-7.
  
  Levi N, Bastuji-Garin S, Mockenhaupt M, Roujeau JC, Flahault A, Kelly JP,Martin E, Kaufman DW, Maison P. Medications as risk factors of Stevens-Johnsonsyndrome and toxic epidermal necrolysis in children: a pooled analysis.Pediatrics. 2009 Feb;123(2):e297-304.
  
  Gener G, Canoui-Poitrine F, Revuz JE, Faye O, Poli F, Gabison G, Pouget F,Viallette C, Wolkenstein P, Bastuji-Garin S. Combination therapy with clindamycinand rifampicin for hidradenitis suppurativa: a series of 116 consecutivepatients. Dermatology. 2009;219(2):148-54. Epub 2009 Jul 8. PubMed
  
  Dauendorffer JN, Bastuji-Garin S, Guéro S, Brousse N, Fraitag S. Shrinkage ofskin excision specimens: formalin fixation is not the culprit. Br J Dermatol.2009 Apr;160(4):810-4. Epub 2009 Jan 13. PubMed
  
  Revuz JE, Canoui-Poitrine F, Wolkenstein P, Viallette C, Gabison G, Pouget F,Poli F, Faye O, Roujeau JC, Bonnelye G, Grob JJ, Bastuji-Garin S. Prevalence andfactors associated with hidradenitis suppurativa: results from two case-controlstudies. J Am Acad Dermatol. 2008 Oct;59(4):596-601.
  
  Farhi D, Bastuji-Garin S, Khosrotehrani K, Vidaud D, Bellane C, Revuz J, Wolkenstein P. Neurofibromatosis 1: analysis of the demand for prenatal diagnosis in a French cohort of 361 patients. Am J Med Genet A. 2008 Jan 15;146A(2):159-65.PubMed PMID: 18076113.
  
  Abecassis S, Bastuji-Garin S, Khosrotehrani K, Zeller J, Revuz J, Wolkenstein P. Age at diagnosis of neurofibromatosis 1: an audit of practice. Dermatology.2008;216(4):347-8. Epub 2008 Feb 15. PubMed
  
  Derancourt C, Bourdon-Lanoy E, Grob JJ, Guillaume JC, Bernard P, Bastuji-Garin S. Multiple large solar lentigos on the upper back as clinical markers of past severe sunburn: a case-control study. Dermatology. 2007;214(1):25-31
  
  Bouaziz JD, Bastuji-Garin S, Poszepczynska-Guigne E, Wechsler J, Bagot M. Relative frequency and survival of patients with primary cutaneous lymphomas: data from a single centre study of 203 patients. Br J Dermatol 2006;154:1206-7J
  
  Jagou M, Bastuji-Garin S, Bourdon-Lanoy E, Penso-Assathiany D, Roujeau JC; Reseau d'Epidemiologie en Dermatologie (RED). Poor agreement between self-reported and dermatologists' diagnoses for five common dermatoses. Br J Dermatol. 2006 Nov;155(5):1006-12.
  Guegan S, Bastuji-Garin S, Poszepczynska-Guigne E, Roujeau JC, Revuz J. Performances of the SCORTEN during the first five days of hospitalisation to predict the prognosis of epidermal necrolysis. J Invest Dermatol 2006;126:272-6
  
  Khosrotehrani K, Bastuji-Garin S, Riccardi VM, Birch P, Friedman JM, Wolkenstein P. Subcutaneous neurofibromas are associated with mortality in neurofibromatosis 1: a cohort study of 703 patients. Am J Med Genet A 2005;132:49-53 (IF 2.063)
  
  Valeyrie-Allanore L, Ismaïli N, Bastuji-Garin S, Zeller J, Wechsler J, Revuz J, Wolkenstein P. Predictive signs in malignant transformation of plexiform neurofibromas: a retrospective study of 69 patients with neurofibromatosis 1. Br J Dermatol 2005; 153:79-82 (IF 3.334)
  
  Guillamo JS, Créange A, Kalifa C, Grill J, Rodriguez D, Doz F, Barbarot S, Zerah M, Sanson M, Bastuji-Garin S, Wolkenstein P for the Reseau NF France. Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients. Brain 2003;126 :152-160 (IF 7.617)
  
  Valeyrie L, Bastuji-Garin S, Revuz J, Bachot N, Wechsler J, Berthaud P, Tulliez M, Giraudier S. Adverse cutaneous reactions to imatinid (STI571) in chromosome Philadelphia positive leukemias. A prospective study of 54 patients. J Am Acad Dermatol 2003;48:201-6 (IF 2.553)
  
  Koshrotherani K, Bastuji-Garin S, Zeller J, Revuz J, Wolkenstein P. Clinical risk factors for morbidity and mortality in neurofibromatosis 1 : a cohort study of 378 patients. Arch dermatol 2003;139:187-191 (IF
  
  Wolkenstein P, Grob JJ, Bastuji-Garin S, Rusczynski S, Roujeau JC, Revuz J on behalf of the French Society of Dermatology. French people and skin diseases: results of a survey using a representative sample. Arch Dermatol 2003; 139:1614-9 (IF 2.851)
  
  De Jonghe B, Sharshar T, Lefaucheur JP, Authier J, Durand-Zaleski I, Boussarsar M, Cerf C, Renaud E, Mesrati F, Carlet J, Raphaël JC, Outin H, Bastuji-Garin S. Paresis acquired in the Intensive Care Unit: a prospective multicenter study. JAMA 2002 ;288 :2859-67 (IF 23.175)
  
  Bastuji-Garin S, Turki H, Mokhtar I, Nouira R, Fazaa B, Jomaa B, Zahaf A, BenOsman A, Souissi R, Hemon D, Roujeau J-C, Kamoun MR. Possible relation of Tunisian pemphigus with traditional cosmetics: a case-control study. Am J Epidemiol, 2002 ; 155 :249-256 (IF 5.241)
  
  Wechler J, Bastuji-Garin S, Spatz A, Bailly C, Andrac L, Vergier B, Fraitag S, Verola O, Cribier B, Wolkenstein P and the French Cutaneous Cancerology Club. Reliability of the histopathologic diagnosis of malignant melanoma in childhood. Arch Dermatol 2002 ; 138 : 625-628 (IF 2.851)
  
  Bastuji-Garin S, Deverly A, Moyse D, Castaigne A, Chatellier G. The Framingham prediction rule is not valid in a European population of treated hypertensive patients. J Hypertens 2002 ;20 :1973-80
  
  Bastuji-Garin S, Ochonisky S, Bouche P, Gherardi RK, Duguet C, Djerradine Z, Poli F, Revuz J on behalf the Thalidomide Neuropathy Study Group Incidence and risk factors for thalidomide neuropathy: a prospective study of 135 dermatological patients. J Invest Dermatol 2002;119 :1020-6 (IF 4.535)
  
  Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P. SCORTEN : a severity-of-illness score for Toxic Epidermal Necrolysis. J Invest Dermatol, 2000 ; 115 : 149-153
  
  Loiseau P, Lecleach L, Prost C, Lepage V, Busson M, Bastuji-Garin S, Roujeau JC, Charron D. HLA class II polymorphism contributes to specific desmoglein derived peptides in pemphigus vulgaris and pemphigus foliaceus. J Autoimmun 2000, 15 : 67-73
  
  Verpilleux MP, Bastuji-Garin S, Revuz J. Comparative analysis of severe aphtosis and Behçet’s disease : 104 cases. Dermatology 1999 ; 198 : 247-251
  
  Bastuji-Garin S, Grob JJ, Grognard C, Grosjean F, Guillaume JC. Melanoma Prevention: evaluation of a health education campaign for primary school. Arch Dermatol 1999 ;135 :936-940
  
  Dupuy A, Benchiki H, Roujeau JC, Bernard Ph, Sassolas B, Chosidow O, Vaillant L, Guillaume JC, Grob JJ, Bastuji-Garin S. Risk factors for erysipelas of the leg (cellulitis): case-control study. Br Med J 1999 ;318 :1591-1594
  
  Mansouri S, Dubertret L, Bastuji-Garin S, Dombret H, Roujeau J-C, Aractingi S. Role of drugs in cutaneous eruptions after chemotherapy for acute myelogenous leukemia. Arch Dermatol 1998 ; 134 : 881-82.
  
  Roujeau JC, Lock C, Bastuji-Garin S, Mhalla S, Enginger V, Bernard P. High risk of death in elderly patients with generalized bullous pemphigoid. Arch Dermatol 1998 ; 134 : 465-69
  
  Bastuji-Garin S, Joly P, Picard C, Bernard P, Vaillant L, Foldès-Pauwells C, Salagnac V, Lok C, Roujeau J-C, the Bullous Disease French Study Group. Drugs associated with bullous pemphigoid. A case-control study. Arch Dermatol 1996;132:272-276
  
  Grob JJ, Bastuji-Garin S, Vaillant L, Roujeau JC, Bernard P, Guillaume JC. Excess of nevi related to immunodeficiency: a study in HIV-infected patients and renal transplant recipients. J Invest Dermatol 1996;107:694-697
  
  Bastuji-Garin S, Souissi R, Blum L, Turki H, Nouira R, Jomaa B, Zahaf A, BenOsman A, Revuz J, Roujeau J-C, Kamoun MR. Comparative epidemiology of pemphigus in France and Tunisia : unusual incidence of pemphigus foliaceus in young tunisian women. J Invest Dermatol 1995 ; 104 : 302-305.
  
  Kelly JP, Auquier A, Rzany B, Naldi L, Bastuji-Garin S, Shapiro S, Kaufman D. An international collaborative case-control study of severe cutaneous adverse drug reaction (SCAR). Design and method. J Clin Epidemiol 1995 ; 48 : 1099-1108.
  
  Assier H, Bastuji-Garin S, Revuz J, Roujeau J-C. Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct etiologies. Arch Dermatol 1995 ; 131 : 539-543.
  
  Côté B, Wechsler J, Bastuji-Garin S, Assier H, Revuz J, Roujeau J-C. Clinico-pathological correlation in Stevens-Johnson syndrome and Erythema multiforme. Arch Dermatol 1995 ;131 :1268-1272
  
  Guibal F, Bastuji-Garin S, Chosidow O, Saiag P, Revuz J, Roujeau J-C. Characteristics of toxic epidermal necrolysis in patients undergoing long-term glucocorticoid therapy. Arch Dermatol 1995 ; 131 : 669-672.
  
  Wolkenstein P, Carrière V, Charrue D, Bastuji-Garin S, Revuz J, Roujeau JC, Beaune P, Bagot M. A slow acetylator genotype is a risk factor for sulfonamide induced toxic epidermal necrolysis and Stevens-Johnson syndrome. Pharmacogenetics 1995 ; 5 : 255-258.
  
  Roujeau JC, Kelly JP, Naldi L, Rzany B, Anderson T, Auquier A, Bastuji-Garin S, Correia O, Locati F, Paoletti C, Shapiro S, Shear N, Schöpf, Stern RS, Kaufman D. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995;333:1600-1607
  
  Ochonisky S, Verroust J, Bastuji-Garin S, Gherardi R, Revuz J. Thalidomide neuropathy incidence and clinicoelectrophysiologic findings in 42 patients. Arch Dermatol 1994 ; 130 : 66-69.
  
  Chosidow O, Chastang C, Brue C, Bouvet E, Izri M, Monteny N, Bastuji-Garin S, Rousset JJ, Revuz J. Controlled study of malathion and d-phenothrin lotions for pediculus humanus var capitis-infested schoolchildren. Lancet 1994 ;344 :1724-1727.
  
  Correia O, Chosidow O, Saiag P, Bastuji-Garin S, Revuz J, Roujeau JC. Evolving pattern of drug-induced toxic epidermal necrolysis. Dermatology 1993;186:32-37.
  
  Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau J-C. A clinical classification of cases of Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome and Erythema Multiforme. Arch Dermatol 1993 ; 129 : 92-96.
  
  Bastuji-Garin S, Zahedi M, Guillaume J-C, Roujeau J-C. Toxic epidermal necrolysis (Lyell syndrome) in 77 elderly patients. Age & ageing 1993 ; 22 : 450-6